Farokhzad, Omid C.
Harvard Medical School,
United States
2024 Rank: 2587
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Enabling & Strategic Technologies
SubField 1:
Nanoscience & Nanotechnology
SubField 2:
Organic Chemistry
Rank in SubField 1: 90 out of 135958 Researchers
Data For The Year: 2024
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 2587 | 2770 |
| Total Cites | 5714 | 5902 |
| H-index | 36 | 37 |
| Hm-index | 14 | 14 |
| Number of Single Authored Papers | 3 | 3 |
| Total Cites to Single Authored Papers | 11 | 11 |
| Number of Single+First Authored Papers | 16 | 16 |
| Total Cites to Single+First Authored Papers | 295 | 295 |
| Number of Single+First+Last Authored Papers | 118 | 118 |
| Total Cites to Single+First+Last Authored Papers | 3348 | 3411 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 4366 | 4437 |
| Ratio of Total Citations to Distinct Citing Papers | 1.31 | 1.33 |
| Self-Citation Percentage |
3.19%
|
|
Farokhzad, Omid C.
Seer, Inc.,
United States
2023 Rank: 2752
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Enabling & Strategic Technologies
SubField 1:
Nanoscience & Nanotechnology
SubField 2:
Organic Chemistry
Rank in SubField 1: 95 out of 117692 Researchers
Data For The Year: 2023
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 2752 | 2986 |
| Total Cites | 6217 | 6483 |
| H-index | 38 | 40 |
| Hm-index | 14 | 14 |
| Number of Single Authored Papers | 3 | 3 |
| Total Cites to Single Authored Papers | 6 | 6 |
| Number of Single+First Authored Papers | 15 | 15 |
| Total Cites to Single+First Authored Papers | 325 | 328 |
| Number of Single+First+Last Authored Papers | 117 | 117 |
| Total Cites to Single+First+Last Authored Papers | 3750 | 3845 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 4630 | 4715 |
| Ratio of Total Citations to Distinct Citing Papers | 1.34 | 1.37 |
| Self-Citation Percentage |
4.10%
|
|
Farokhzad, Omid C.
Seer, Inc.,
United States
2022 Rank: 2020
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Enabling & Strategic Technologies
SubField 1:
Nanoscience & Nanotechnology
SubField 2:
Organic Chemistry
Rank in SubField 1: 68 out of 103235 Researchers
Data For The Year: 2022
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 2020 | 2121 |
| Total Cites | 6628 | 7023 |
| H-index | 39 | 41 |
| Hm-index | 14 | 14 |
| Number of Single Authored Papers | 3 | 3 |
| Total Cites to Single Authored Papers | 9 | 9 |
| Number of Single+First Authored Papers | 16 | 16 |
| Total Cites to Single+First Authored Papers | 358 | 358 |
| Number of Single+First+Last Authored Papers | 116 | 116 |
| Total Cites to Single+First+Last Authored Papers | 3980 | 4153 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 4793 | 4909 |
| Ratio of Total Citations to Distinct Citing Papers | 1.38 | 1.43 |
| Self-Citation Percentage |
5.62%
|
|
Farokhzad, Omid C.
Harvard Medical School,
United States
2021 Rank: 1984
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Enabling & Strategic Technologies
SubField 1:
Nanoscience & Nanotechnology
SubField 2:
Biomedical Engineering
Rank in SubField 1: 68 out of 89177 Researchers
Data For The Year: 2021
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 1984 | 2131 |
| Total Cites | 9777 | 10113 |
| H-index | 48 | 51 |
| Hm-index | 15 | 16 |
| Number of Single Authored Papers | 3 | 3 |
| Total Cites to Single Authored Papers | 16 | 16 |
| Number of Single+First Authored Papers | 15 | 15 |
| Total Cites to Single+First Authored Papers | 578 | 578 |
| Number of Single+First+Last Authored Papers | 112 | 112 |
| Total Cites to Single+First+Last Authored Papers | 6317 | 6471 |
| Composite Score | 4 | 4 |
| Number of Distinct Citing Papers | 7039 | 7169 |
| Ratio of Total Citations to Distinct Citing Papers | 1.39 | 1.41 |
| Self-Citation Percentage |
3.32%
|
|
Farokhzad, Omid C.
Brigham and Women's Hospital,
United States
2020 Rank: 1740
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Enabling & Strategic Technologies
SubField 1:
Nanoscience & Nanotechnology
SubField 2:
Biomedical Engineering
Rank in SubField 1: 64 out of 75210 Researchers
Data For The Year: 2020
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 1740 | 1925 |
| Total Cites | 7478 | 7802 |
| H-index | 43 | 45 |
| Hm-index | 14 | 14 |
| Number of Single Authored Papers | 3 | 3 |
| Total Cites to Single Authored Papers | 12 | 12 |
| Number of Single+First Authored Papers | 15 | 15 |
| Total Cites to Single+First Authored Papers | 478 | 482 |
| Number of Single+First+Last Authored Papers | 112 | 112 |
| Total Cites to Single+First+Last Authored Papers | 4950 | 5124 |
| Composite Score | 4 | 4 |
| Number of Distinct Citing Papers | 5345 | 5475 |
| Ratio of Total Citations to Distinct Citing Papers | 1.40 | 1.43 |
| Self-Citation Percentage |
4.15%
|
|
Related Profiles
Featured Profiles
Partner with Us
📢 Reach a targeted audience of science enthusiasts and professionals through our platform. Contact our marketing team:
business@topscinet.com cc: top2percentscientist@gmail.comGet a custom proposal tailored to your banner ad goals.
Partner with Us
📢 Partner with us and reach a targeted audience of science enthusiasts and professionals through our platform. Your company/institute’s banner could be here.